Skip to content

I CARE study; Improving Care After colon canceR treatment in the Netherlands. -Personalised care to Enhance quality of life-

I CARE study; Improving Care After colon canceR treatment in the Netherlands. -Personalised care to Enhance quality of life-

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON24929
Enrollment
300
Registered
2014-10-02
Start date
2015-01-01
Completion date
Unknown
Last updated
2025-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

1. Primary care-led follow-up and aftercare 2. Interactive personal website (Oncokompas)

Sponsors

Academic Medical Center, Amsterdam
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: - Carcinoma located in the colon and rectosigmoid defined as a tumour located 15 cm above the anal verge by coloscopy or above the sacral promontory as seen preoperatively - Stage 1, 2 and 3 carcinoma - Surgical treatment with curative intent - Qualified for routine follow-up attendance by surgeon according to the national guideline. - Patients with temporary stoma and who received adjuvant chemotherapy are also eligible.

Exclusion criteria

Exclusion criteria: - Stage IV colorectal tumours - Hereditary colorectal cancer - Colorectal cancer in patients with inflammatory bowel disease - Rectal cancer - (Sub)total colectomy or proctocolectomy - History of second primary cancer (except basal cell carcinoma of the skin) within the last 15 years - Participation in other (clinical) research, which will affect the outcome measurements of this trial - Permanent open wounds after surgery or other conditions where specialised care is needed - Any other condition that warrants increased intensity of surveillance with respect to colon cancer follow-up - Not able to speak Dutch or English

Design outcomes

Primary

MeasureTime frame
Quality of life and patients' satisfaction

Secondary

MeasureTime frame
Physical outcomes, psychosocial outcomes, number of investigations, referrals and related communication between secondary and primary care, (time) of recurrence detection, protocol adherence, attention to preventive care, cost effectiveness, and preference of care at the end of the trial

Contacts

Public ContactJ. Wind

Academic Medical Center (AMC), P.O. Box 22660

J.Wind@amc.uva.nl+31 (0)20 5663170

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)